Hana Golan
Overview
Explore the profile of Hana Golan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anchoo C, Lev A, Simon A, Levy S, Mandola A, Frizinsky S, et al.
J Allergy Clin Immunol
. 2025 Feb;
PMID: 39900265
Background: Hematopoietic stem cell transplantation (HSCT) is a curative treatment for infants with severe combined immunodeficiency (SCID). Different factors determine HSCT success and overall survival (OS). Specifically, prompt diagnosis of...
2.
Yardeni M, Shaked O, Pienik R, Ben-Ami M, Stern E, Golan H, et al.
Nutrients
. 2023 Sep;
15(18).
PMID: 37764717
Objective: The COVID-19 pandemic and associated social distancing measures affected the physical and emotional state of children and parents worldwide. Survivors of childhood cancer may be particularly vulnerable to these...
3.
Chowers G, Abebe-Campino G, Golan H, Vivante A, Greenberger S, Soudack M, et al.
Pediatr Res
. 2023 Aug;
94(6):2117.
PMID: 37550488
No abstract available.
4.
Jacoby E, Bar-Yosef O, Gruber N, Lahav E, Varda-Bloom N, Bolkier Y, et al.
Sci Transl Med
. 2022 Dec;
14(676):eabo3724.
PMID: 36542693
Patients with single large-scale mitochondrial DNA (mtDNA) deletion syndromes (SLSMDs) usually present with multisystemic disease, either as Pearson syndrome in early childhood or as Kearns-Sayre syndrome later in life. No...
5.
Freund T, Baxter S, Walsh T, Golan H, Kapelushnik J, Abramsohn-Goldenberg M, et al.
J Clin Immunol
. 2022 Sep;
43(1):151-164.
PMID: 36063261
Pathogenic variants in LRBA, encoding the LPS Responsive Beige-Like Anchor (LRBA) protein, are responsible for recessive, early-onset hypogammaglobulinemia, severe multi-organ autoimmunity, and lymphoproliferation, with increased risk for malignancy. LRBA deficiency...
6.
Golan H, Mechoulam R, Smoum R, Cohen-Zada E, Pri-Chen S, Wiener S, et al.
Biomedicines
. 2022 Jul;
10(7).
PMID: 35884854
Modulation of the endogenous cannabinoid system has been suggested as a potential anticancer strategy. In the search for novel and less toxic therapeutic options, structural modifications of the endocannabinoid anandamide...
7.
Barg A, Levy-Mendelovich S, Gilad O, Yacobovich J, Tamarin I, Budnik I, et al.
Pediatr Blood Cancer
. 2022 Jul;
69(10):e29888.
PMID: 35856619
This is the first study examining real-life data of pediatric cancer patients treated with rivaroxaban. Children with thrombocytopenia and high bleeding risk were excluded from previous clinical trials. Data regarding...
8.
Chowers G, Abebe-Campino G, Golan H, Vivante A, Greenberger S, Soudack M, et al.
Pediatr Res
. 2022 Mar;
94(6):1911-1915.
PMID: 35246606
Background: Kaposiform lymphangiomatosis (KLA) is a complex lymphatic anomaly involving most commonly the mediastinum, lung, skin and bones with few effective treatments. In recent years, RAS-MAPK pathway mutations were shown...
9.
Laronne A, Granek L, Wiener L, Feder-Bubis P, Golan H
Pediatr Blood Cancer
. 2021 Dec;
69(3):e29533.
PMID: 34958524
Introduction: This study explored pediatric oncology healthcare professionals' (HCPs) perspectives on direct communication with children with advanced disease about their disease, palliative care, and end-of-life (EOL) communication. Methods: Forty-six pediatric...
10.
Laronne A, Granek L, Wiener L, Feder-Bubis P, Golan H
Palliat Med
. 2021 Jul;
35(8):1612-1624.
PMID: 34219546
Background: Pediatric palliative care has established benefits for children with cancer and their families. Overcoming organizational and healthcare provider barriers have been demonstrated as central for the provision of palliative...